11:08 AM EST, 12/19/2024 (MT Newswires) -- European equities traded in the US as American depositary receipts were moving slightly lower late Thursday morning, declining 0.16% to 1,302.71 on the 11.

From continental Europe, the gainers were led by financial services company ING (ING) and biopharmaceutical company Grifols ( GRFS ) , which were up 2.6% and 2.4% respectively. They were followed by petroleum refiner Equinor ( EQNR ) and internet browser company Opera (OPRA), which increased 2.3% and 1.7% respectively.

The decliners from continental Europe were led by biopharmaceutical companies DBV Technologies ( DBVT ) and Genfit ( GNFT ) , which dropped 8.5% and 4.6% respectively. They were followed by hotel booking site trivago (TRVG) and biopharmaceutical company Cellectis ( CLLS ) , which were down 4.2% and 2.5% respectively.

From the UK and Ireland, the gainers were led by biopharmaceutical company Akari Therapeutics ( AKTX ) and software firm Endava ( DAVA ) , which rose 5.1% and 4.3% respectively. They were followed by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company Verona Pharma ( VRNA ) , which advanced 3.3% and 1.9% respectively.

The decliners from the UK and Ireland were led by biopharmaceutical companies Amarin ( AMRN ) and Adaptimmune Therapeutics ( ADAP ) , which fell 3.4% and 2.2% respectively. They were followed by biopharmaceutical company Biodexa Pharmaceuticals ( BDRX ) and pharmaceutical company Silence Therapeutics ( SLN ) , which were off 1.8% and 1.1% respectively.